Correction to: The Cost Effectiveness of Genetic Testing for CYP2C19 Variants to Guide Thienopyridine Treatment in Patients with Acute Coronary Syndromes.
- Published in:
- 2020
- By:
- Publication type:
- corrected article
Works matching IS 11707690 AND DT 2020 AND VI 38 AND IP 3
Results: 8
1
2
Reflections on NICE's Uptake of New Methods: Past, Present, and the 2020 Review.
- Published in:
- 2020
- By:
- Publication type:
- Letter
3
After 20 Years of Using Economic Evaluation, Should NICE be Considered a Methods Innovator?
- Published in:
- 2020
- By:
- Publication type:
- journal article
4
Challenges of Systematic Reviews of Economic Evaluations: A Review of Recent Reviews and an Obesity Case Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
5
Multi-criteria Decision Analysis Software in Healthcare Priority Setting: A Systematic Review.
- Published in:
- 2020
- By:
- Publication type:
- journal article
6
Economic Impact of Early-in-Hospital Diagnosis and Initiation of Eculizumab in Atypical Haemolytic Uraemic Syndrome.
- Published in:
- 2020
- By:
- Publication type:
- journal article
7
Healthcare Expenditures for the Treatment of Patients Infected with Hepatitis C Virus in Japan.
- Published in:
- 2020
- By:
- Publication type:
- journal article
8
Potential Bias Associated with Modeling the Effectiveness of Healthcare Interventions in Reducing Mortality Using an Overall Hazard Ratio.
- Published in:
- 2020
- By:
- Publication type:
- journal article